Baidu
map

葛均波院士等发表《泛血管病防治科学声明》:改变以疾病为中心和以临床事件为中心的防治模式

2019-12-02 中国循环杂志 循环

近日,上海复旦大学附属中山医院葛均波院士等在本刊发表了《泛血管病防治科学声明》。声明指出,由于学科的细分,以冠脉疾病、卒中、外周动脉疾病为代表的泛血管疾病等被列入不同的学科,由心血管内科、神经内科、心脏外科、神经外科、血管外科、放射科等不同科室分别进行管理。因此,各个学科过度关注局部的病变,而忽视全身系统性血管病变的问题,导致不同学科对同一种疾病的诊治策略产生显着的差异。而泛血管医学是从系统生物学

近日,上海复旦大学附属中山医院葛均波院士等在本刊发表了《泛血管病防治科学声明》。



声明指出,由于学科的细分,以冠脉疾病、卒中、外周动脉疾病为代表的泛血管疾病等被列入不同的学科,由心血管内科、神经内科、心脏外科、神经外科、血管外科、放射科等不同科室分别进行管理

因此,各个学科过度关注局部的病变,而忽视全身系统性血管病变的问题,导致不同学科对同一种疾病的诊治策略产生显着的差异。

而泛血管医学是从系统生物学角度重新和统一认识血管性疾病的发生发展规律及特征,提出多学科交叉、跨学科整合的研究模式和发展理念。

声明建议,应当“改变当今以“以疾病为中心”和“以临床事件为中心”的防治模式,泛血管疾病防治策略应坚持“以患者为中心”和“以促进健康为中心”的全方位、全周期管理理念。”

声明也指出,泛血管医学是基于多学科合作和跨学科整合理念的新兴学科,应围绕“全链条部署、一体化实施”的原则和“协同创新、交融式研究”的模式进行建设。

声明建议构建泛血管疾病的防治平台、研究平台和产业平台,从基础到临床不同层面探索泛血管疾病的致病机制和有效防控策略,整合三级诊疗体系,建立疾病中心进行“防治康养”全程管理。

来源:杨靖,王克强,霍勇,等. 泛血管疾病综合防治科学声明. 中国循环杂志, 2019, 34: 1041.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1644808, encodeId=c4471644808cf, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Tue Feb 11 02:37:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706350, encodeId=0dcb1e06350fc, content=<a href='/topic/show?id=a5c76491203' target=_blank style='color:#2F92EE;'>#泛血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64912, encryptionId=a5c76491203, topicName=泛血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893a31226591, createdName=ms2999106592497887, createdTime=Tue Sep 15 14:37:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990322, encodeId=00bb199032212, content=<a href='/topic/show?id=21ad9e43442' target=_blank style='color:#2F92EE;'>#防治模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97434, encryptionId=21ad9e43442, topicName=防治模式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Thu Mar 19 01:37:00 CST 2020, time=2020-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626285, encodeId=8d2816262859b, content=<a href='/topic/show?id=44ca88222d2' target=_blank style='color:#2F92EE;'>#葛均波院士#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88222, encryptionId=44ca88222d2, topicName=葛均波院士)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a63720999381, createdName=hjwang86, createdTime=Wed Dec 04 00:37:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049156, encodeId=41e61049156f4, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Dec 02 12:37:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1644808, encodeId=c4471644808cf, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Tue Feb 11 02:37:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706350, encodeId=0dcb1e06350fc, content=<a href='/topic/show?id=a5c76491203' target=_blank style='color:#2F92EE;'>#泛血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64912, encryptionId=a5c76491203, topicName=泛血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893a31226591, createdName=ms2999106592497887, createdTime=Tue Sep 15 14:37:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990322, encodeId=00bb199032212, content=<a href='/topic/show?id=21ad9e43442' target=_blank style='color:#2F92EE;'>#防治模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97434, encryptionId=21ad9e43442, topicName=防治模式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Thu Mar 19 01:37:00 CST 2020, time=2020-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626285, encodeId=8d2816262859b, content=<a href='/topic/show?id=44ca88222d2' target=_blank style='color:#2F92EE;'>#葛均波院士#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88222, encryptionId=44ca88222d2, topicName=葛均波院士)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a63720999381, createdName=hjwang86, createdTime=Wed Dec 04 00:37:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049156, encodeId=41e61049156f4, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Dec 02 12:37:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1644808, encodeId=c4471644808cf, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Tue Feb 11 02:37:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706350, encodeId=0dcb1e06350fc, content=<a href='/topic/show?id=a5c76491203' target=_blank style='color:#2F92EE;'>#泛血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64912, encryptionId=a5c76491203, topicName=泛血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893a31226591, createdName=ms2999106592497887, createdTime=Tue Sep 15 14:37:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990322, encodeId=00bb199032212, content=<a href='/topic/show?id=21ad9e43442' target=_blank style='color:#2F92EE;'>#防治模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97434, encryptionId=21ad9e43442, topicName=防治模式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Thu Mar 19 01:37:00 CST 2020, time=2020-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626285, encodeId=8d2816262859b, content=<a href='/topic/show?id=44ca88222d2' target=_blank style='color:#2F92EE;'>#葛均波院士#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88222, encryptionId=44ca88222d2, topicName=葛均波院士)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a63720999381, createdName=hjwang86, createdTime=Wed Dec 04 00:37:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049156, encodeId=41e61049156f4, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Dec 02 12:37:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1644808, encodeId=c4471644808cf, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Tue Feb 11 02:37:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706350, encodeId=0dcb1e06350fc, content=<a href='/topic/show?id=a5c76491203' target=_blank style='color:#2F92EE;'>#泛血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64912, encryptionId=a5c76491203, topicName=泛血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893a31226591, createdName=ms2999106592497887, createdTime=Tue Sep 15 14:37:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990322, encodeId=00bb199032212, content=<a href='/topic/show?id=21ad9e43442' target=_blank style='color:#2F92EE;'>#防治模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97434, encryptionId=21ad9e43442, topicName=防治模式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Thu Mar 19 01:37:00 CST 2020, time=2020-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626285, encodeId=8d2816262859b, content=<a href='/topic/show?id=44ca88222d2' target=_blank style='color:#2F92EE;'>#葛均波院士#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88222, encryptionId=44ca88222d2, topicName=葛均波院士)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a63720999381, createdName=hjwang86, createdTime=Wed Dec 04 00:37:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049156, encodeId=41e61049156f4, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Dec 02 12:37:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1644808, encodeId=c4471644808cf, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Tue Feb 11 02:37:00 CST 2020, time=2020-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706350, encodeId=0dcb1e06350fc, content=<a href='/topic/show?id=a5c76491203' target=_blank style='color:#2F92EE;'>#泛血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64912, encryptionId=a5c76491203, topicName=泛血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893a31226591, createdName=ms2999106592497887, createdTime=Tue Sep 15 14:37:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1990322, encodeId=00bb199032212, content=<a href='/topic/show?id=21ad9e43442' target=_blank style='color:#2F92EE;'>#防治模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97434, encryptionId=21ad9e43442, topicName=防治模式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Thu Mar 19 01:37:00 CST 2020, time=2020-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626285, encodeId=8d2816262859b, content=<a href='/topic/show?id=44ca88222d2' target=_blank style='color:#2F92EE;'>#葛均波院士#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88222, encryptionId=44ca88222d2, topicName=葛均波院士)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a63720999381, createdName=hjwang86, createdTime=Wed Dec 04 00:37:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049156, encodeId=41e61049156f4, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Dec 02 12:37:00 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
    2019-12-02 junJUN

    院士是学术至高点,也是大家必争之地呀

    0

Baidu
map
Baidu
map
Baidu
map